NEW YORK – An international team of researchers has found that assessing T cells in primary melanomas can help clinicians predict metastatic recurrence in patients whose cancerous lesions have been surgically resected.
NEW YORK – An international team of researchers has found that assessing T cells in primary melanomas can help clinicians predict metastatic recurrence in patients whose cancerous lesions have been surgically resected.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.